Cargando…
Focal segmental glomerulosclerosis: molecular genetics and targeted therapies
Recent advances show that human focal segmental glomerulosclerosis (FSGS) is a primary podocytopathy caused by podocyte-specific gene mutations including NPHS1, NPHS2, WT-1, LAMB2, CD2AP, TRPC6, ACTN4 and INF2. This review focuses on genes discovered in the investigation of complex FSGS pathomechani...
Autores principales: | Chen, Ying Maggie, Liapis, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496884/ https://www.ncbi.nlm.nih.gov/pubmed/26156092 http://dx.doi.org/10.1186/s12882-015-0090-9 |
Ejemplares similares
-
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007) -
Focal Segmental Glomerulosclerosis: Genetics, Mechanism, and Therapies
por: Kronbichler, Andreas, et al.
Publicado: (2016) -
Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016) -
Unwinding focal segmental glomerulosclerosis
por: Peev, Vasil, et al.
Publicado: (2017) -
Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis—a review
por: Löwik, M. M., et al.
Publicado: (2009)